We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+5.31%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$23B
AUM Growth
-$233M
Cap. Flow
-$880M
Cap. Flow %
-3.82%
Top 10 Hldgs %
33.31%
Holding
1,606
New
44
Increased
614
Reduced
449
Closed
86

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$63.2M
2
EXP icon
Eagle Materials
EXP
+$56.2M
3
ITRI icon
Itron
ITRI
+$54.4M
4
AAPL icon
Apple
AAPL
+$52.6M
5
ENPH icon
Enphase Energy
ENPH
+$40.6M

Top Sells

Rank Stock Value
1
COO icon
Cooper Companies
COO
+$82.8M
2
NVDA icon
NVIDIA
NVDA
+$76M
3
MSFT icon
Microsoft
MSFT
+$62.6M
4
ADBE icon
Adobe
ADBE
+$62.2M
5
JBL icon
Jabil
JBL
+$41M

Sector Composition

Rank Sector Weight
1 Technology 36.79%
2 Healthcare 19.28%
3 Financials 10.14%
4 Communication Services 9.05%
5 Industrials 8.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRHC icon
1451
Freedom Holding
FRHC
$9.35B
$241K ﹤0.01%
3,200
STBA icon
1452
S&T Bancorp
STBA
$1.82B
$241K ﹤0.01%
7,216
CWK icon
1453
Cushman & Wakefield Ltd
CWK
$3.29B
$239K ﹤0.01%
23,000
NNI icon
1454
Nelnet
NNI
$4.51B
$237K ﹤0.01%
2,351
MRVI icon
1455
Maravai LifeSciences
MRVI
$870M
$236K ﹤0.01%
32,900
+7,400
+29% +$63.9K
VIR icon
1456
Vir Biotechnology
VIR
$1.55B
$235K ﹤0.01%
26,400
+3,900
+17% +$37.4K
UPWK icon
1457
Upwork
UPWK
$1.04B
$233K ﹤0.01%
21,700
+1,100
+5% +$12.5K
SDGR icon
1458
Schrodinger
SDGR
$1.39B
$232K ﹤0.01%
12,000
+1,600
+15% +$36.9K
APPN icon
1459
Appian
APPN
$2.46B
$231K ﹤0.01%
7,500
+700
+10% +$23K
LESL icon
1460
Leslie's
LESL
$7.02M
$230K ﹤0.01%
2,750
ZUO
1461
DELISTED
Zuora, Inc.
ZUO
$225K ﹤0.01%
22,700
+1,500
+7% +$14.4K
CIM
1462
Chimera Investment
CIM
$1B
$224K ﹤0.01%
17,487
USPH icon
1463
US Physical Therapy
USPH
$1.23B
$222K ﹤0.01%
2,400
SPNT icon
1464
SiriusPoint
SPNT
$2.68B
$221K ﹤0.01%
18,088
-1,600
-8% -$20K
XPEL icon
1465
XPEL
XPEL
$1.36B
$221K ﹤0.01%
6,222
+1,000
+19% +$43.1K
FBNC icon
1466
First Bancorp
FBNC
$2.73B
$218K ﹤0.01%
6,844
FVRR icon
1467
Fiverr
FVRR
$312M
$218K ﹤0.01%
+9,300
New +$209K
INTA icon
1468
Intapp
INTA
$3.02B
$216K ﹤0.01%
+5,900
New +$201K
PHR icon
1469
Phreesia
PHR
$763M
$216K ﹤0.01%
+10,200
New +$221K
ASAN icon
1470
Asana
ASAN
$2.04B
$214K ﹤0.01%
15,300
+1,000
+7% +$14.3K
NVEE
1471
DELISTED
NV5 Global
NVEE
$214K ﹤0.01%
9,200
WS icon
1472
Worthington Steel
WS
$1.94B
$214K ﹤0.01%
+6,416
New +$210K
DRVN icon
1473
Driven Brands
DRVN
$2.11B
$213K ﹤0.01%
16,700
+4,500
+37% +$57K
PLYA
1474
DELISTED
Playa Hotels & Resorts
PLYA
$212K ﹤0.01%
25,300
ADEA icon
1475
Adeia
ADEA
$3.15B
$211K ﹤0.01%
18,900

Similar funds

Handelsbanken Fonder's Q2 2024 Portfolio in Review

As of Q2 2024, Handelsbanken Fonder held 1,606 positions worth $23B, down 1% from $23.2B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Handelsbanken Fonder withdrew a net $880M in Q2 2024, closing 86 positions and reducing 449 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $20.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Handelsbanken Fonder opened a new position in Kenvue worth $12.8M.

  • Handelsbanken Fonder's largest Q2 2024 buy was Kenvue: 701,911 shares worth $12.8M.
  • Handelsbanken Fonder added most to Vertex Pharmaceuticals in Q2 2024, an estimated $63.2M increase.
  • Handelsbanken Fonder's biggest Q2 2024 reduction was Cooper Companies, cutting an estimated $82.8M.
  • Handelsbanken Fonder fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $20.6M.
  • Handelsbanken Fonder's ten largest holdings make up 33% of its $23B portfolio in Q2 2024.
  • Handelsbanken Fonder opened 44 new positions and closed 86 in Q2 2024.
  • Handelsbanken Fonder's portfolio value fell 1% quarter-over-quarter to $23B.

Based on Handelsbanken Fonder's 13F filing for Q2 2024, filed 5 Aug 2024.